Pathway in Medical Technology

VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE

... have discovered a key disease-related biologic pathway using an integrated and innovative array of in ... technologies. The newly reported biologic pathway relates to monocyte deployment from the spleen to ... scientists discovered and detailed the biologic pathway through the use of a series of advanced and ...

Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients

... types are associated with aberrations of the PI3K pathway that commonly lead to resistance and poor ... of tumor tissue confirmed inhibition of the PI3K pathway by complete absence of a downstream target (pS6). ... cascades can lead to cancer and aberrant PI3K pathway activity is observed with high frequency in a ...

Mayo Researchers Help Discover Genetic Cause for Primary Biliary Cirrhosis

... biliary cirrhosis. These two genes constitute a pathway of the immune system. Potential therapeutic manipulation of this pathway provides new possibilities for more effective ... "Although both the HLA region and the IL12 pathway are equally involved with susceptibility to ...

FDA Accepts Arno Therapeutics' IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway

... PDK1 inhibitor that blocks the PI3K/Akt pathway and induces the endoplasmic reticulum stress ... PDK1 inhibitor that blocks the PI3K/Akt pathway and induces the endoplasmic reticulum stress ... available PDK1 inhibitor that blocks the PI3K/Akt pathway and induces the endoplasmic reticulum stress ...

Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting

... complex inhibitor of the PI3K/Akt/mTOR pathway showing efficacy in retinal scarring caused by ... "Palomid 529, An Inhibitor of the Akt/mTOR pathway Reduces Photoreceptor Cell Death Following ... inhibiting the PI3K/Akt/mTor signal transduction pathway by Palomid 529 may be neuroprotective to ...

Semafore Achieves a Preclinical Milestone with SF2626, a PI3K-MEK Dual Pathway Kinase Inhibitor

... of both the PI3K (Phosphoinositide-3-kinase) pathway and the Ras-MAPK (Ras-mitogen activated protein ... both pathways in treating cancer. Both the PI3K pathway and the Ras-MAPK pathways have emerged as central ... scientific studies demonstrate that the Ras-MAPK pathway has the ability to cross-talk to the ...

DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program

... believe we understand the anticipated regulatory pathway for the Phase III program and approval, which we expect will follow a 505(b)2 pathway as discussed with FDA. (Logo: ... utilized in the Phase III program) and regulatory pathway for approval, our intentions to enter into ...

The Children's Hospital of Philadelphia: New Gene-Searching Method Uncovers Possible New Targets for Crohn's Disease Drugs

... Crohn's disease. Hakonarson added that the IL12 pathway might be more correctly referred to as the ... cell receptors at some points on a biological pathway may produce clinical improvements, but with side ... Association Studies Associate the IL12/23 pathway with Crohn's Disease," The American Journal of ...

IBT Laboratories Expands its Menu of Tests for Immune Deficiency

... Fx TM test and the Mannan Binding Lectin (MBL) pathway Function Test , at the November 2008 meeting of ... improve health outcomes." The MBL pathway is one of the most important components of the ... a unique and quantitative serum test (MBL pathway Function Test) to evaluate the effectiveness of ...

Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer

... cancer. Studies suggest that the PD-1 signaling pathway may play an important role in tumor evasion and ... or PD-L2) is an important negative regulation pathway that suppresses or inhibits activated ... that antibodies targeting the PD-1 signaling pathway reinvigorate antigen-specific T-cell responses ...

In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop

... Data support targeting the alternative complement pathway using TT30 as an immunomodulatory compound for ... potential of targeting the alternative pathway in complement-mediated diseases, the study showed ... critical importance of the alternative complement pathway in ischemia-reperfusion injury but also ...

Data from In Vivo Disease Models on Taligen Therapeutics' Pipeline Candidates to be Presented at the XXII International Complement Workshop

... that targeting the alternative complement pathway can impact complement-mediated inflammatory ... TT30 Targeted inhibition of the alternative pathway by CR2-fH fusion protein ameliorates progression ... Session 2, Poster 174 Alternative complement pathway signaling in a mouse model of ...

SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines

... of a very powerful pathway, the PI3/AKT /mTOR pathway that has been shown to play a major role in ... I clinical trials, was shown to block the pAKT pathway through which the angiogenic factors VEGF and Bv8 ... In vitro inhibition of the PI3K/AKT/mTOR pathway by SF1126 was demonstrated to impede the ability ...

Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters

... Therapeutics that Modulate Alternative pathway of Complement System CAMBRIDGE, Mass., July 23 ... that are designed to modulate the alternative pathway of the complement system," said Dr. Emlen. "We ... and validated the importance of the alternative pathway as an amplification loop in the inflammation ...

GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer

... The system, MetaMiner (Oncology) will combine pathway and network analysis tools, act as a OMICs data ... "MetaMiner (Oncology) is a new generation pathway analysis tool, specifically tailored for ... between the involved pathways and the dynamics of pathway activation during tumorigenesis. These are two ...

Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments

... studies suggest RAD001 may help overcome a major pathway of resistance to ... vessel growth in cancer cells. "The mTOR pathway is a major route to resistance in targeted ... that RAD001, an inhibitor of mTOR, acts on the pathway that mediates trastuzumab resistance and has the ...

Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO

... Robust pathway Inhibition in Tumor and Surrogate Tissues at ... Reductions of 80-90% in the phosphorylation of pathway components including AKT, 4EBP1, and S6, and ... first time, we have seen inhibition of the PI3K pathway in humans, with good tolerability. The data ...

Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing

... targeting PI3-kinase (PI3-K). The PI3-K pathway is known to play an important role in disease ... In cancer, up-regulation of the PI 3-K pathway is a very common characteristic and several components of the pathway are implicated in the development of cancer. In ...

Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models

... stimulating the Wnt pathway, a signaling pathway that is critical for cell growth and ... Rspo proteins are novel regulators of the Wnt pathway and were first identified by Nuvelo as potent ... and preclinical candidate NU206, a Wnt pathway modulator for the potential treatment of ...

EntreMed Commences Continuous Dosing Clinical Trial For MKC-1

... of the mTOR/rictor pathway. The PI3K-Akt- mTOR pathway is the most frequently mutated pathway in human tumors. Mutations in this pathway have been shown to promote tumor progression and ...

Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics

... Pathway-targeted Therapeutics To date, ErbB pathway abnormalities, which occur in a large number ... there are 7 approved agents targeting this pathway and over 620 clinical trials are ongoing with ... to the success or failure of the ErbB pathway inhibitors. A series of reports ( ...

Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics

... on the importance of establishing a regulatory pathway in the U.S. for large molecule protein-based ... awareness of the need for Congress to establish a pathway for approval of FOBs, which would enhance patient ... "Given Europe's previously established regulatory pathway for FOBs, the U.S. is clearly lagging behind ...

EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model

... of the oncogenic kinase Akt and the mTOR pathway are known to be adverse prognostic factors and ... to MKC-1. MKC-1 inhibited both Akt and mTOR pathway activation in vitro, and was further evaluated in ... of the mTOR/rictor pathway. The Akt-mTOR pathway is the most frequently mutated pathway in human ...

FASgen Announces Significant Milestone in Its Cancer Drug Development Program

... treatment of cancer. The fatty acid biosynthesis pathway is critical to all living organisms to produce ... do not produce fat, the fatty acid biosynthesis pathway in the transformed cell acts to regulate the ... keeps the cell alive. One critical enzyme in that pathway is FAS. The Company's researchers have discovered ...

Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development

... more than 50 novel agents targeting this pathway are in development. "The ErbB pathway in Cancer" is a series of comprehensive ... costs in the USA and ROW -- Detailed ErbB pathway analyses -- Associations of ErbB expression and ...

Boston University Biomedical Engineers Find Chink in Bacteria's Armor

... Michael Kohanski, "and the endpoint of this pathway is excessive free radical production." Free ... damagers," said Kohanski. This hidden pathway and resultant free radical overload appears to ... the pipeline, if this free-radical producing pathway is exploited to lower the therapeutic dose, ...

Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug

... program to develop new chemical entities that target a recently discovered pathway in the pathophysiology of chronic obstructive pulmonary diseases. For ... program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease may not be ...

Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R)

... afflicted with breast cancer. Theranostics Health will use its pathway mapping platform to measure signaling pathway activation in hundreds of key signaling proteins directly from randomly ...

Clinical Data on Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, to be Presented at the 2009 ASCO Meeting

... of the PI3 kinase signaling cascades can lead to cancer and aberrant PI3K pathway activity is observed with high frequency in a variety of tumor types. ... of the PI3 kinase and PTEN cell signaling pathway, a promising target pathway for multiple disorders, including the company's focus - cancer. Semafore ...

CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License

... such as trauma, severe pneumonia and sepsis. ALI is a key factor on the pathway to mortality following severe influenza infection. About IC14 ... Lung inflammation in response to innate immune activation through the TLR pathway is a primary factor in the early pathogenesis of ALI. About CMC ICOS ...

Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures

... program to develop new chemical entities that target a recently discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For ... program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease may not be ...

Duska Therapeutics Completes Corporate Name Change to Cordex Pharma

... program to develop new chemical entities that target a recently discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For ... program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease may not be ...

Solace Pharmaceuticals Initiates Phase IIa Trial of Glial Cell Modulator SLC022 in Post-Herpetic Neuralgia

... Professor Channon is a world-leading expert in the biochemistry of the BH4 pathway and the vascular endothelial system. Dr. Channon's work complements Solace's work in the development of small-molecule inhibitors of the BH4 pathway for treating chronic pain. "We believe that the collaboration ...

Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis

... an inflammatory disease highly correlated with a molecular signaling pathway that can be inhibited by SYI-2074. About Psoriasis ... and hormonal factors play a role. It is also known that the TNF-alpha pathway plays a role in the progression of the disease. Other companies have ...

Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology

... on Akt are of particular interest because of the importance of this pathway in the development of most cancers, the evidence that it is often ... encountered thus far in the discovery of drugs that will inhibit this pathway without causing excessive toxicity. High levels of activated Akt (pAkt) ...

Duska Therapeutics Applies for Phase 3 Special Protocol Assessment

... program to develop new chemical entities that target a recently discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. ... and the development of new chemical entities to target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. The ...

Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report

... suggest that BP1 is an important upstream factor in the carcinogenic pathway of prostate cancer and that the expression of BP1 may reflect or directly ... suggest that BP1 may be an important regulatory factor in the oncogenic pathway of several malignancies including prostate cancer." Berg stated today, ...

New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis

... nervous system can control inflammation in RA. The group identified a new pathway that allows the spinal cord and brain to decrease joint inflammation and joint destruction. Now that this pathway is identified, new therapies can be developed to utilize it and mimic the ...

New Genes Found for Inflammatory Bowel Disease in Children

... candidate, because it is already known to participate in the biological pathway of a protein called tumor necrosis factor (TNF). TNF is a cytokine, a ... said Baldassano, who added, "If better knowledge of the disease pathway enables pharmaceutical companies to develop anti-TNF drugs in pill form, ...

Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors

... of the PI3 kinase and PTEN cell signaling pathway, a promising target pathway for multiple disorders, including the company's focus -- cancer. Semafore ... differentiation, and survival. Dysregulation of the PI3K signaling pathway is believed to play an integral role in the genesis of many cancers ...